Research in Brief
Learn about how researchers were able to predict the onset of Alzheimer’s disease (AD) using MRI.
Learn about how an international research team studying a form of dry age-related macular degeneration (AMD) discovered that two drugs used to treat human immunodeficiency virus (HIV), the virus that can lead to AIDS can block the retinal pigment epithelium (RPE) degeneration found in AMD.
Learn about a new 3D model of the neurovascular unit which helps to study how the vasculature contributes to neurodegenerative disease.
Learn about an implantable wireless device has identified new ways to help physicians diagnose and monitor glaucoma.
Learn about how researchers made a more accurate model of Alzheimer's disease using skin cells.
Learn about the first successful attempt to transplant lab-grown retinal ganglion cells (RGCs) into the eyes of mice to find a cure for glaucoma.
Learn about how a test allows clinicians to accurately detect signs of Alzheimer's Disease from a single blood draw.
A team of medical researchers and bioengineers developed a three-dimensional (3D) matrix model of wet age-related macular degeneration (AMD) that can help with understanding what causes the disease and find effective treatments.
A study of 131 older adults shows that driving behavior may be a good way to identify Alzheimer’s disease before other symptoms appear.
Tau is a protein that misfolds in Alzheimer’s disease, causing it to accumulate and aggregate in the brain, contributing to cognitive decline. Mice engineered to lack tau are protected from neuronal damage, and when levels of tau are reduced in mouse models of Alzheimer’s, their memory improves. Therefore, reducing tau may be a good therapeutic option for AD.